who should not take glp 1 receptor agonists GLP-1 as Treatments for Type 2 Diabetes The GLP-1 Agonists and Obesity:

In fact, there is not even a single clinical trial or any published evidence that evaluates its efficacy & safety as a skin-whitening agent

Urothelial cell culture: stratified urothelial sheet and three-dimensional growth of urothelial structure

A multicenter randomized study demonstrated that carvedilol (a non-selective -blocker with intrinsic anti-1 activity) combined with simvastatin reduced HVPG by 18.9% versus 12.5% with carvedilol alone in cirrhosis patients with suboptimal response to traditional -blockers, concurrently attenuating postprandial endothelial dysfunction and proinflammatory cytokines (IL-6, MCP-1) 75

1. Longevity & Geroprotection

Projects funded ranged from studies evaluating the impact of electronic cigarette use among HIV positive smokers to evaluating free radical production from charcoal filters